Chen, L., Chiou, W., Lin, H., Lee, M., Lo, Y., Huang, L., . . . Hung, S. (2019). Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial. BMC Cancer.
Styl ChicagoChen, Liang-Cheng, et al. "Comparing Stereotactic Ablative Radiotherapy (SABR) Versus Re-trans-catheter Arterial Chemoembolization (re-TACE) for Hepatocellular Carcinoma Patients Who Had Incomplete Response After Initial TACE (TASABR): A Randomized Controlled Trial." BMC Cancer 2019.
Citace podle MLAChen, Liang-Cheng, et al. "Comparing Stereotactic Ablative Radiotherapy (SABR) Versus Re-trans-catheter Arterial Chemoembolization (re-TACE) for Hepatocellular Carcinoma Patients Who Had Incomplete Response After Initial TACE (TASABR): A Randomized Controlled Trial." BMC Cancer 2019.